Clinical Trial Update: A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study evaluating a quadruplet regimen of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DARZALEX (daratumumab)
• DEXAMETHASONE (Dexamethasone)
• Kyprolis (carfilzomib)
• Revlimid (lenalidomide)

Snippet

Sponsor: University of Miami | Conditions: Multiple Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING